Postoperative Pulmonary Complications in Elderly Patients Undergoing Major Abdominal Surgery

NCT ID: NCT07306897

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

239 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to identify the risk factors associated with postoperative pulmonary complications (PPCs) in patients aged 65 years and older who undergo major abdominal surgery.

The study is designed as a retrospective observational analysis using data from patient records.

Understanding these risk factors may help clinicians improve perioperative care and reduce the risk of respiratory problems after surgery in elderly patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective observational study. No follow-up was performed; all data were collected from existing patient records.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: Patients with postoperative pulmonary complications (PPC +)

Group 1 - Patients with postoperative pulmonary complications (PPC +):

This group includes patients aged 65 years and older who underwent major abdominal surgery and developed one or more postoperative pulmonary complications, as defined by EPCO criteria

No interventions assigned to this group

Group 2: Patients without postoperative pulmonary complications (PPC -)

Group 2 - Patients without postoperative pulmonary complications (PPC -):

This group includes patients aged 65 years and older who underwent major abdominal surgery but did not develop any postoperative pulmonary complications.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 65 years or older.
* Patients who underwent major abdominal surgery at \[Institution Name\].
* Availability of complete perioperative and postoperative clinical records.
* Postoperative hospital stay of at least 24 hours.

Exclusion Criteria

* Patients younger than 65 years.
* Patients undergoing minor or non-abdominal surgery.
* Incomplete or missing perioperative or postoperative medical records.
* Patients who underwent emergency surgery
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arif Timuroğlu, MD

specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arif Timuroğlu

Role: PRINCIPAL_INVESTIGATOR

ankara oncology trainig and research hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital

Ankara, Ankara, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PPC65-MAS-2024

Identifier Type: -

Identifier Source: org_study_id